4.7 Review

Potential therapeutic compounds from traditional Chinese medicine targeting endoplasmic reticulum stress to alleviate rheumatoid arthritis

期刊

PHARMACOLOGICAL RESEARCH
卷 170, 期 -, 页码 -

出版社

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.phrs.2021.105696

关键词

Rheumatoid arthritis; Endoplasmic reticulum stress; Traditional Chinese medicine; Therapeutic drug; Stress modulation

资金

  1. Guangdong Basic and Applied Basic Research Foundation, China [2020B1515130005]
  2. 2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund, China (Guangdong-Hong Kong-Macau Joint Lab) [2020B1212030006]
  3. FDCT, Macao S.A.R., China grants
  4. Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery from the Macao Science and Technology Development Fund, Macao S.A.R., China [0048/2018/A2, 001/2020/ALC]
  5. Foshan Medicine Dengfeng Project of China, China (2019-2021)

向作者/读者索取更多资源

Rheumatoid arthritis is a chronic inflammatory autoimmune disease affecting approximately 0.5-1% of the population, requiring new treatment options. Endoplasmic reticulum stress has been associated with rheumatoid arthritis, cancer, and inflammatory pathologies, with some traditional Chinese medicines showing potential in modulating ER stress.
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease which affects about 0.5-1% of people with symptoms that significantly impact a sufferer's lifestyle. The cells involved in propagating RA tend to display pro-inflammatory and cancer-like characteristics. Medical drug treatment is currently the main avenue of RA therapy. However, drug options are limited due to severe side effects, high costs, insufficient disease retardation in a majority of patients, and therapeutic effects possibly subsiding over time. Thus there is a need for new drug therapies. Endoplasmic reticulum (ER) stress, a condition due to accumulation of misfolded proteins in the ER, and subsequent cellular responses have been found to be involved in cancer and inflammatory pathologies, including RA. ER stress protein markers and their modulation have therefore been suggested as therapeutic targets, such as GRP78 and CHOP, among others. Some current RA therapeutic drugs have been found to have ER stress-modulating properties. Traditional Chinese Medicines (TCMs) frequently use natural products that affect multiple body and cellular targets, and several medicines and/or their isolated compounds have been found to also have ER stress-modulating capabilities, including TCMs used in RA treatment by Chinese Medicine practitioners. This review encourages, in light of the available information, the study of these RA-treating, ER stressmodulating TCMs as potential new pharmaceutical drugs for use in clinical RA therapy, along with providing a list of other ER stress-modulating TCMs utilized in treatment of cancers, inflammatory diseases and other diseases, that have potential use in RA treatment given similar ER stress-modulating capacity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据